(ARCB) ArcBest - Overview
Stock: LTL, Freight, Logistics, Brokerage
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.68% |
| Yield on Cost 5y | 1.21% |
| Yield CAGR 5y | 10.67% |
| Payout Consistency | 74.0% |
| Payout Ratio | 17.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 51.6% |
| Relative Tail Risk | -14.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | -5.72 |
| Character TTM | |
|---|---|
| Beta | 1.686 |
| Beta Downside | 1.380 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.45% |
| CAGR/Max DD | 0.07 |
Description: ARCB ArcBest January 15, 2026
ArcBest Corp (NASDAQ:ARCB) operates as an integrated logistics provider, delivering ground, air, and ocean transportation worldwide through two distinct business lines. The Asset-Based segment focuses on less-than-truckload (LTL) freight across a broad product mix and extends motor carrier services into Mexico via partner trucking firms. The Asset-Light segment functions as a brokerage platform, arranging third-party capacity for dry-van, temperature-controlled, flatbed, intermodal, and container shipments, while also offering warehousing, managed transportation, final-mile, and specialty logistics services.
Recent financial disclosures (FY 2023) show ArcBest generated roughly **$4.1 billion** in revenue with an adjusted EBITDA margin near **8 %**, reflecting modest profitability despite volatile fuel costs. The LTL segment reported a **2 % year-over-year volume increase**, driven largely by sustained e-commerce growth, which has lifted demand for time-critical, small-batch deliveries. A key sector-wide risk remains the **driver shortage** and **fuel price exposure**, both of which can compress margins if not mitigated through pricing power or efficiency initiatives.
For a deeper, data-driven view of how ArcBest’s valuation compares to peers, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 60.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 3.56 > 1.0 |
| NWC/Revenue: -0.77% < 20% (prev 0.23%; Δ -1.00% < -1%) |
| CFO/TA 0.09 > 3% & CFO 229.0m > Net Income 60.1m |
| Net Debt (566.9m) to EBITDA (265.8m): 2.13 < 3 |
| Current Ratio: 0.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.5m) vs 12m ago -5.55% < -2% |
| Gross Margin: 5.42% > 18% (prev 0.08%; Δ 533.9% > 0.5%) |
| Asset Turnover: 164.3% > 50% (prev 172.0%; Δ -7.72% > 0%) |
| Interest Coverage Ratio: 7.72 > 6 (EBITDA TTM 265.8m / Interest Expense TTM 12.4m) |
Altman Z'' 3.50
| A: -0.01 (Total Current Assets 626.1m - Total Current Liabilities 656.9m) / Total Assets 2.45b |
| B: 0.61 (Retained Earnings 1.48b / Total Assets 2.45b) |
| C: 0.04 (EBIT TTM 95.5m / Avg Total Assets 2.44b) |
| D: 1.28 (Book Value of Equity 1.48b / Total Liabilities 1.16b) |
| Altman-Z'' Score: 3.50 = A |
Beneish M -2.76
| DSRI: 0.90 (Receivables 397.3m/459.5m, Revenue 4.01b/4.18b) |
| GMI: 1.54 (GM 5.42% / 8.38%) |
| AQI: 0.93 (AQ_t 0.19 / AQ_t-1 0.20) |
| SGI: 0.96 (Revenue 4.01b / 4.18b) |
| TATA: -0.07 (NI 60.1m - CFO 229.0m) / TA 2.45b) |
| Beneish M-Score: -2.76 (Cap -4..+1) = A |
What is the price of ARCB shares?
Over the past week, the price has changed by +12.24%, over one month by +29.08%, over three months by +69.18% and over the past year by +21.61%.
Is ARCB a buy, sell or hold?
- StrongBuy: 4
- Buy: 2
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the ARCB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 97.4 | -13% |
| Analysts Target Price | 97.4 | -13% |
| ValueRay Target Price | 114.5 | 2.2% |
ARCB Fundamental Data Overview February 09, 2026
P/E Forward = 22.8311
P/S = 0.6285
P/B = 1.9312
P/EG = 3.0
Revenue TTM = 4.01b USD
EBIT TTM = 95.5m USD
EBITDA TTM = 265.8m USD
Long Term Debt = 135.5m USD (from longTermDebt, two quarters ago)
Short Term Debt = 124.3m USD (from shortTermDebt, last quarter)
Debt = 668.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 566.9m USD (from netDebt column, last quarter)
Enterprise Value = 3.07b USD (2.52b + Debt 668.9m - CCE 124.2m)
Interest Coverage Ratio = 7.72 (Ebit TTM 95.5m / Interest Expense TTM 12.4m)
EV/FCF = 22.95x (Enterprise Value 3.07b / FCF TTM 133.5m)
FCF Yield = 4.36% (FCF TTM 133.5m / Enterprise Value 3.07b)
FCF Margin = 3.33% (FCF TTM 133.5m / Revenue TTM 4.01b)
Net Margin = 1.50% (Net Income TTM 60.1m / Revenue TTM 4.01b)
Gross Margin = 5.42% ((Revenue TTM 4.01b - Cost of Revenue TTM 3.79b) / Revenue TTM)
Gross Margin QoQ = -0.85% (prev 8.22%)
Tobins Q-Ratio = 1.25 (Enterprise Value 3.07b / Total Assets 2.45b)
Interest Expense / Debt = 0.50% (Interest Expense 3.32m / Debt 668.9m)
Taxrate = 27.68% (23.0m / 83.1m)
NOPAT = 69.0m (EBIT 95.5m * (1 - 27.68%))
Current Ratio = 0.95 (Total Current Assets 626.1m / Total Current Liabilities 656.9m)
Debt / Equity = 0.52 (Debt 668.9m / totalStockholderEquity, last quarter 1.30b)
Debt / EBITDA = 2.13 (Net Debt 566.9m / EBITDA 265.8m)
Debt / FCF = 4.25 (Net Debt 566.9m / FCF TTM 133.5m)
Total Stockholder Equity = 1.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.46% (Net Income 60.1m / Total Assets 2.45b)
RoE = 4.61% (Net Income TTM 60.1m / Total Stockholder Equity 1.30b)
RoCE = 6.63% (EBIT 95.5m / Capital Employed (Equity 1.30b + L.T.Debt 135.5m))
RoIC = 4.51% (NOPAT 69.0m / Invested Capital 1.53b)
WACC = 9.66% (E(2.52b)/V(3.19b) * Re(12.13%) + D(668.9m)/V(3.19b) * Rd(0.50%) * (1-Tc(0.28)))
Discount Rate = 12.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.68%
[DCF Debug] Terminal Value 65.84% ; FCFF base≈98.5m ; Y1≈72.1m ; Y5≈41.0m
Fair Price DCF = 1.37 (EV 597.4m - Net Debt 566.9m = Equity 30.5m / Shares 22.3m; r=9.66% [WACC]; 5y FCF grow -31.56% → 2.90% )
EPS Correlation: -70.97 | EPS CAGR: -55.21% | SUE: -0.79 | # QB: 0
Revenue Correlation: -90.95 | Revenue CAGR: -6.83% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.19 | Chg30d=-0.076 | Revisions Net=-3 | Analysts=13
EPS current Year (2026-12-31): EPS=4.48 | Chg30d=-0.457 | Revisions Net=-2 | Growth EPS=+21.1% | Growth Revenue=+3.7%
EPS next Year (2027-12-31): EPS=7.20 | Chg30d=-0.032 | Revisions Net=+2 | Growth EPS=+60.6% | Growth Revenue=+6.5%